BETTERLIFE PHARMA INC.: 10-Q filed 2014-06-16

Name: BETTERLIFE PHARMA INC.: 10-Q filed 2014-06-16
Creator: BETTERLIFE PHARMA INC.

What BETTERLIFE PHARMA INC. reported in its quarterly report filed 2014-06-16 (fiscal Q1 2015): 20 published measures, 42 facts as tagged in accession 0001511164-14-000358.

This filing

Form: 10-Q (quarterly report)
Filed: 2014-06-16
Fiscal period: fiscal Q1 2015
Accession: 0001511164-14-000358 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BETTERLIFE PHARMA INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2014-04-30	6,736	CAD
At 2014-01-31	7,167	CAD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2014-04-30	573,485	CAD
At 2014-01-31	757,680	CAD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2014-04-30	480	CAD
At 2014-01-31	1,044	CAD
At 2013-04-30	15,143	CAD
At 2013-01-31	475	CAD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2014-02-01 to 2014-04-30	90,764	CAD	89
2002-06-10 to 2014-04-30	-2,823,483	CAD	4343
2013-02-01 to 2013-04-30	-49,016	CAD	89

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2014-02-01 to 2014-04-30	-564	CAD	89
2002-06-10 to 2014-04-30	-555,531	CAD	4343
2013-02-01 to 2013-04-30	-332	CAD	89

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2002-06-10 to 2014-04-30	558,287	CAD	4343
2013-02-01 to 2013-04-30	15,000	CAD	89

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2002-06-10 to 2014-04-30	-2,276	CAD	4343

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2014-04-30	552,558	CAD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2014-02-01 to 2014-04-30	101,441,230	shares	89
2013-02-01 to 2013-04-30	35,767,073	shares	89

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2014-04-30	758	USD
At 2014-01-31	872	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2002-06-10 to 2014-04-30	61,911	CAD	4343

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2014-04-30	5,978	CAD
At 2014-01-31	6,295	CAD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2014-02-01 to 2014-04-30	-9,071	CAD	89
2002-06-10 to 2014-04-30	-130,229	CAD	4343
2013-02-01 to 2013-04-30	-7,647	CAD	89

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2014-04-30	558,536	CAD
At 2014-01-31	728,915	CAD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2014-02-01 to 2014-04-30	8,194	CAD	89
2002-06-10 to 2014-04-30	1,577,294	CAD	4343
2013-02-01 to 2013-04-30	13,550	CAD	89

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2002-06-10 to 2014-04-30	282,715	CAD	4343

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2014-04-30	115,767,073	shares
At 2014-01-31	100,767,073	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2014-04-30	757,586	CAD
At 2014-01-31	754,586	CAD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2014-02-01 to 2014-04-30	3,439	CAD	89
2002-06-10 to 2014-04-30	250,377	CAD	4343
2013-02-01 to 2013-04-30	2,681	CAD	89

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2002-06-10 to 2014-04-30	307,493	CAD	4343

Inspect the source

Entity: BETTERLIFE PHARMA INC. / CIK 0001464165
Captured: 2026-09-20T09:06:34.124Z
SEC response SHA-256: da89258f023cbc29ad1ecdd31014873fa96a7739fba3e7b66a8b80f8715d36cf

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001464165.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))